1. Search Result
Search Result
Results for "

F5

" in MedChemExpress (MCE) Product Catalog:

45

Inhibitors & Agonists

3

Fluorescent Dye

6

Peptides

2

Inhibitory Antibodies

2

Natural
Products

7

Recombinant Proteins

2

Antibodies

28

Oligonucleotides

Cat. No. Product Name Target Research Areas Chemical Structure
  • HY-108277

    Apoptosis Cancer
    Ginsenoside F5, from crude extracts of flower buds of Panax ginseng, remarkably inhibits the growth of HL-60 cells by the apoptosis pathway .
    Ginsenoside F5
  • HY-W010811

    Amino Acid Derivatives Others
    Fmoc-Phe(F5)-OH is a phenylalanine derivative .
    Fmoc-Phe(F5)-OH
  • HY-RS04644

    Small Interfering RNA (siRNA) Others

    F5 Human Pre-designed siRNA Set A contains three designed siRNAs for F5 gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

    F5 Human Pre-designed siRNA Set A
    F5 Human Pre-designed siRNA Set A
  • HY-N8311

    NF-κB Inflammation/Immunology
    Goshonoside F5 can be isolated from the unripe fruits of Rubus chingii. Goshonoside F5 has anti-inflammatory activity, and inhibits NF-κB and MAPK signaling pathway .
    Goshonoside F5
  • HY-N7736

    Furan Fatty acid F5

    Endogenous Metabolite Metabolic Disease
    12,15-epoxy-13-methyl-12,14-Eicosadienoic acid is a furan fatty acid originally isolated from northern pike (E. lucius).1 Levels of 12,15-epoxy-13-methyl-12,14-eicosadienoic acid are increased in the liver of starving cod.
    Furan fatty acid F5
  • HY-10278

    DPC 906; BMS 561389

    Factor Xa Others
    F5&" is a bioavtive small molecular compound."
    Razaxaban
  • HY-D1410

    DMTr-4'-F-5-Methyluridine-CED phosphoramidite

    Fluorescent Dye Others
    DMTr-4'-F-5-Me-U-CED phosphoramidite (DMTr-4'-F-5-Methyluridine-CED phosphoramidite), a dye reagent for oligonucleotide labeling, acts as efficient as the incorporation of native deoxyribonucleoside phosphoramidites. DMTr-4'-F-5-Me-U-CED phosphoramidite is a building block .
    DMTr-4'-F-5-Me-U-CED phosphoramidite
  • HY-P4020

    HIV Others
    2F5 epitope, a peptide gp41 (659-671), comprises the entire epitope for one of the three known antibodies capable of neutralizing a broad spectrum of primary HIV-1 isolates and is the only such epitope that is sequential. 2F5 epitope is recognized by broadly neutralizing antibodies 2F5 .
    2F5 epitope
  • HY-R01575

    MicroRNA Cancer
    hsa-miR-518f-5p mimics are small, chemically synthesized double-stranded RNAs that mimic endogenous miRNAs and enable miRNA functional analysis by up-regulation of miRNA activity.
    hsa-miR-518f-5p mimic
    hsa-miR-518f-5p mimic
  • HY-R01604

    MicroRNA Cancer
    hsa-miR-520f-5p mimics are small, chemically synthesized double-stranded RNAs that mimic endogenous miRNAs and enable miRNA functional analysis by up-regulation of miRNA activity.
    hsa-miR-520f-5p mimic
    hsa-miR-520f-5p mimic
  • HY-R01684

    MicroRNA Cancer
    hsa-miR-548f-5p mimics are small, chemically synthesized double-stranded RNAs that mimic endogenous miRNAs and enable miRNA functional analysis by up-regulation of miRNA activity.
    hsa-miR-548f-5p mimic
    hsa-miR-548f-5p mimic
  • HY-R03052

    MicroRNA Cancer
    mmu-miR-344f-5p mimics are small, chemically synthesized double-stranded RNAs that mimic endogenous miRNAs and enable miRNA functional analysis by up-regulation of miRNA activity.
    mmu-miR-344f-5p mimic
    mmu-miR-344f-5p mimic
  • HY-R03177

    MicroRNA Cancer
    mmu-miR-466f-5p mimics are small, chemically synthesized double-stranded RNAs that mimic endogenous miRNAs and enable miRNA functional analysis by up-regulation of miRNA activity.
    mmu-miR-466f-5p mimic
    mmu-miR-466f-5p mimic
  • HY-R03468

    MicroRNA Cancer
    mmu-miR-669f-5p mimics are small, chemically synthesized double-stranded RNAs that mimic endogenous miRNAs and enable miRNA functional analysis by up-regulation of miRNA activity.
    mmu-miR-669f-5p mimic
    mmu-miR-669f-5p mimic
  • HY-RS04114

    Small Interfering RNA (siRNA) Others

    E2F5 Human Pre-designed siRNA Set A contains three designed siRNAs for E2F5 gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

    E2F5 Human Pre-designed siRNA Set A
    E2F5 Human Pre-designed siRNA Set A
  • HY-RS09816

    Small Interfering RNA (siRNA) Others

    OR4F5 Human Pre-designed siRNA Set A contains three designed siRNAs for OR4F5 gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

    OR4F5 Human Pre-designed siRNA Set A
    OR4F5 Human Pre-designed siRNA Set A
  • HY-RI01575

    MicroRNA Cancer
    hsa-miR-518f-5p inhibitors are chemically-modified oligonucleotides that hybridize with mature miRNAs. The miRNA inhibitors have full-length nucleotide 2'-methoxy modification. The miRNA inhibitors strongly compete with mature miRNAs to prevent the complementary pairing of miRNAs and their target genes, thereby inhibiting miRNAs from functioning.
    hsa-miR-518f-5p inhibitor
    hsa-miR-518f-5p inhibitor
  • HY-RI01604

    MicroRNA Cancer
    hsa-miR-520f-5p inhibitors are chemically-modified oligonucleotides that hybridize with mature miRNAs. The miRNA inhibitors have full-length nucleotide 2'-methoxy modification. The miRNA inhibitors strongly compete with mature miRNAs to prevent the complementary pairing of miRNAs and their target genes, thereby inhibiting miRNAs from functioning.
    hsa-miR-520f-5p inhibitor
    hsa-miR-520f-5p inhibitor
  • HY-RI01684

    MicroRNA Cancer
    hsa-miR-548f-5p inhibitors are chemically-modified oligonucleotides that hybridize with mature miRNAs. The miRNA inhibitors have full-length nucleotide 2'-methoxy modification. The miRNA inhibitors strongly compete with mature miRNAs to prevent the complementary pairing of miRNAs and their target genes, thereby inhibiting miRNAs from functioning.
    hsa-miR-548f-5p inhibitor
    hsa-miR-548f-5p inhibitor
  • HY-RI03052

    MicroRNA Cancer
    mmu-miR-344f-5p inhibitors are chemically-modified oligonucleotides that hybridize with mature miRNAs. The miRNA inhibitors have full-length nucleotide 2'-methoxy modification. The miRNA inhibitors strongly compete with mature miRNAs to prevent the complementary pairing of miRNAs and their target genes, thereby inhibiting miRNAs from functioning.
    mmu-miR-344f-5p inhibitor
    mmu-miR-344f-5p inhibitor
  • HY-RI03177

    MicroRNA Cancer
    mmu-miR-466f-5p inhibitors are chemically-modified oligonucleotides that hybridize with mature miRNAs. The miRNA inhibitors have full-length nucleotide 2'-methoxy modification. The miRNA inhibitors strongly compete with mature miRNAs to prevent the complementary pairing of miRNAs and their target genes, thereby inhibiting miRNAs from functioning.
    mmu-miR-466f-5p inhibitor
    mmu-miR-466f-5p inhibitor
  • HY-RI03468

    MicroRNA Cancer
    mmu-miR-669f-5p inhibitors are chemically-modified oligonucleotides that hybridize with mature miRNAs. The miRNA inhibitors have full-length nucleotide 2'-methoxy modification. The miRNA inhibitors strongly compete with mature miRNAs to prevent the complementary pairing of miRNAs and their target genes, thereby inhibiting miRNAs from functioning.
    mmu-miR-669f-5p inhibitor
    mmu-miR-669f-5p inhibitor
  • HY-R01575A

    MicroRNA Cancer
    hsa-miR-518f-5p agomirs are chemically-modified double-strand miRNA mimics with modified mature miRNA strand: 2 phosphorothioates at the 5' end, 4 phosphorothioates at the 3' end, 3' end cholesterol group, and full-length nucleotide 2'-methoxy modification. They are designed to mimic endogenous miRNAs and recommended for miRNA functional studies. Compared with miRNA mimics, they exhibits enhanced cellular uptake, stability and regulatory activity in vivo.
    hsa-miR-518f-5p agomir
    hsa-miR-518f-5p agomir
  • HY-R01604A

    MicroRNA Cancer
    hsa-miR-520f-5p agomirs are chemically-modified double-strand miRNA mimics with modified mature miRNA strand: 2 phosphorothioates at the 5' end, 4 phosphorothioates at the 3' end, 3' end cholesterol group, and full-length nucleotide 2'-methoxy modification. They are designed to mimic endogenous miRNAs and recommended for miRNA functional studies. Compared with miRNA mimics, they exhibits enhanced cellular uptake, stability and regulatory activity in vivo.
    hsa-miR-520f-5p agomir
    hsa-miR-520f-5p agomir
  • HY-R01684A

    MicroRNA Cancer
    hsa-miR-548f-5p agomirs are chemically-modified double-strand miRNA mimics with modified mature miRNA strand: 2 phosphorothioates at the 5' end, 4 phosphorothioates at the 3' end, 3' end cholesterol group, and full-length nucleotide 2'-methoxy modification. They are designed to mimic endogenous miRNAs and recommended for miRNA functional studies. Compared with miRNA mimics, they exhibits enhanced cellular uptake, stability and regulatory activity in vivo.
    hsa-miR-548f-5p agomir
    hsa-miR-548f-5p agomir
  • HY-R03052A

    MicroRNA Cancer
    mmu-miR-344f-5p agomirs are chemically-modified double-strand miRNA mimics with modified mature miRNA strand: 2 phosphorothioates at the 5' end, 4 phosphorothioates at the 3' end, 3' end cholesterol group, and full-length nucleotide 2'-methoxy modification. They are designed to mimic endogenous miRNAs and recommended for miRNA functional studies. Compared with miRNA mimics, they exhibits enhanced cellular uptake, stability and regulatory activity in vivo.
    mmu-miR-344f-5p agomir
    mmu-miR-344f-5p agomir
  • HY-R03177A

    MicroRNA Cancer
    mmu-miR-466f-5p agomirs are chemically-modified double-strand miRNA mimics with modified mature miRNA strand: 2 phosphorothioates at the 5' end, 4 phosphorothioates at the 3' end, 3' end cholesterol group, and full-length nucleotide 2'-methoxy modification. They are designed to mimic endogenous miRNAs and recommended for miRNA functional studies. Compared with miRNA mimics, they exhibits enhanced cellular uptake, stability and regulatory activity in vivo.
    mmu-miR-466f-5p agomir
    mmu-miR-466f-5p agomir
  • HY-R03468A

    MicroRNA Cancer
    mmu-miR-669f-5p agomirs are chemically-modified double-strand miRNA mimics with modified mature miRNA strand: 2 phosphorothioates at the 5' end, 4 phosphorothioates at the 3' end, 3' end cholesterol group, and full-length nucleotide 2'-methoxy modification. They are designed to mimic endogenous miRNAs and recommended for miRNA functional studies. Compared with miRNA mimics, they exhibits enhanced cellular uptake, stability and regulatory activity in vivo.
    mmu-miR-669f-5p agomir
    mmu-miR-669f-5p agomir
  • HY-RI01575A

    MicroRNA Cancer
    hsa-miR-518f-5p antagomirs are chemically-modified oligonucleotides that hybridize with mature miRNAs. The miRNA antagomirs have 2 phosphorothioates at the 5' end, 4 phosphorothioates at the 3' end, 1 cholesterol group at the 3' end, and full-length nucleotide 2'-methoxy modification. The miRNA antagomirs strongly compete with mature miRNAs to prevent the complementary pairing of miRNAs and their target genes, thereby inhibiting miRNAs from functioning. Stability of miRNA antagomirs appears to be significantly higher than miRNA inhibitors, they exhibits enhanced cellular uptake, stability and regulatory activity in vivo.
    hsa-miR-518f-5p antagomir
    hsa-miR-518f-5p antagomir
  • HY-RI01604A

    MicroRNA Cancer
    hsa-miR-520f-5p antagomirs are chemically-modified oligonucleotides that hybridize with mature miRNAs. The miRNA antagomirs have 2 phosphorothioates at the 5' end, 4 phosphorothioates at the 3' end, 1 cholesterol group at the 3' end, and full-length nucleotide 2'-methoxy modification. The miRNA antagomirs strongly compete with mature miRNAs to prevent the complementary pairing of miRNAs and their target genes, thereby inhibiting miRNAs from functioning. Stability of miRNA antagomirs appears to be significantly higher than miRNA inhibitors, they exhibits enhanced cellular uptake, stability and regulatory activity in vivo.
    hsa-miR-520f-5p antagomir
    hsa-miR-520f-5p antagomir
  • HY-RI01684A

    MicroRNA Cancer
    hsa-miR-548f-5p antagomirs are chemically-modified oligonucleotides that hybridize with mature miRNAs. The miRNA antagomirs have 2 phosphorothioates at the 5' end, 4 phosphorothioates at the 3' end, 1 cholesterol group at the 3' end, and full-length nucleotide 2'-methoxy modification. The miRNA antagomirs strongly compete with mature miRNAs to prevent the complementary pairing of miRNAs and their target genes, thereby inhibiting miRNAs from functioning. Stability of miRNA antagomirs appears to be significantly higher than miRNA inhibitors, they exhibits enhanced cellular uptake, stability and regulatory activity in vivo.
    hsa-miR-548f-5p antagomir
    hsa-miR-548f-5p antagomir
  • HY-RI03052A

    MicroRNA Cancer
    mmu-miR-344f-5p antagomirs are chemically-modified oligonucleotides that hybridize with mature miRNAs. The miRNA antagomirs have 2 phosphorothioates at the 5' end, 4 phosphorothioates at the 3' end, 1 cholesterol group at the 3' end, and full-length nucleotide 2'-methoxy modification. The miRNA antagomirs strongly compete with mature miRNAs to prevent the complementary pairing of miRNAs and their target genes, thereby inhibiting miRNAs from functioning. Stability of miRNA antagomirs appears to be significantly higher than miRNA inhibitors, they exhibits enhanced cellular uptake, stability and regulatory activity in vivo.
    mmu-miR-344f-5p antagomir
    mmu-miR-344f-5p antagomir
  • HY-RI03177A

    MicroRNA Cancer
    mmu-miR-466f-5p antagomirs are chemically-modified oligonucleotides that hybridize with mature miRNAs. The miRNA antagomirs have 2 phosphorothioates at the 5' end, 4 phosphorothioates at the 3' end, 1 cholesterol group at the 3' end, and full-length nucleotide 2'-methoxy modification. The miRNA antagomirs strongly compete with mature miRNAs to prevent the complementary pairing of miRNAs and their target genes, thereby inhibiting miRNAs from functioning. Stability of miRNA antagomirs appears to be significantly higher than miRNA inhibitors, they exhibits enhanced cellular uptake, stability and regulatory activity in vivo.
    mmu-miR-466f-5p antagomir
    mmu-miR-466f-5p antagomir
  • HY-RI03468A

    MicroRNA Cancer
    mmu-miR-669f-5p antagomirs are chemically-modified oligonucleotides that hybridize with mature miRNAs. The miRNA antagomirs have 2 phosphorothioates at the 5' end, 4 phosphorothioates at the 3' end, 1 cholesterol group at the 3' end, and full-length nucleotide 2'-methoxy modification. The miRNA antagomirs strongly compete with mature miRNAs to prevent the complementary pairing of miRNAs and their target genes, thereby inhibiting miRNAs from functioning. Stability of miRNA antagomirs appears to be significantly higher than miRNA inhibitors, they exhibits enhanced cellular uptake, stability and regulatory activity in vivo.
    mmu-miR-669f-5p antagomir
    mmu-miR-669f-5p antagomir
  • HY-P990255

    CXCR Others
    Anti-Mouse CXCL9/MIG Antibody (MIG-2F5.5) is a Armenian hamster-derived IgG, κ type antibody inhibitor, targeting to mouse CXCL9/MIG.
    Anti-Mouse CXCL9/MIG Antibody (MIG-2F5.5)
  • HY-P990221

    Interleukin Related Others
    Anti-Mouse IL-17F Antibody (MM17F8F5.1A9) is a mouse-derived IgG1, κ type antibody inhibitor, targeting to mouse IL-17F.
    Anti-Mouse IL-17F Antibody (MM17F8F5.1A9)
  • HY-P0039

    Bombesin Receptor Cancer
    BIM-26226, gastrin-releasing peptide, is a potent and selective antagonist of bombesin receptor. BIM-26226 inhibits BN- or GRP-stimulated amylase release with IC50s in the nanomolar range. BIM-26226 can be used for the research of cancer .
    BIM-26226
  • HY-W093272

    Ligands for E3 Ligase Autophagy Apoptosis Cancer
    Thalidomide-5,6-F is the Thalidomide-based cereblon ligand used in the recruitment of CRBN protein. Thalidomide-5,6-F can be connected to the ligand for protein by a linker to form PROTACs .
    Thalidomide-5,6-F
  • HY-124421

    NSC-703786

    Aryl Hydrocarbon Receptor Others
    5F-203 (NSC-703786) is a cytotoxic molecule that forms DNA adducts and cell cycle arrest. 5F-203 induces aryl hydrocarbon receptor (AhR) signaling and elevates expression of CYP1A1. 5F-203 also increases the levels of reactive oxygen species as well as activates JNK, ERK, and p38 .
    5F-203
  • HY-D1779

    Fluorescent Dye Others
    Fura-5F pentapotassium is a cell-impermeant fluorescent calcium indicator.
    Fura-5F pentapotassium
  • HY-P5367

    PMDM6-F

    Fluorescent Dye Others
    5-FAM-PMDM6 (PMDM6-F) is a biological active peptide. (PMDM6-F is a fluorescent-labeled probe for MDM2-binding assay.)
    5-FAM-PMDM6
  • HY-112698

    p62 Atg8/LC3 Autophagy Apoptosis Cancer
    CA-5f is a potent late-stage macroautophagy/autophagy inhibitor via inhibiting autophagosome-lysosome fusion. CA-5f increases LC3B-II (a marker to monitor autophagy) and SQSTM1 protein, and also increases ROS production. Anti-tumor activity .
    CA-5f
  • HY-147698

    CDK Topoisomerase Apoptosis Cancer
    ZLHQ-5f is a dual CDK2 and Topo I inhibitor with an IC50 of 0.145 μM against CDK2/CycA2. ZLHQ-5f arrests the cell cycle in S-phase, triggers apoptosis in HCT116 cells, and has a good safety profile .
    ZLHQ-5f
  • HY-D1758

    Fluorescent Dye Others
    Fura-5F AM is a membrane-permeant fluorescent calcium indicator. Upon entering the cell, this probe is hydrolyzed by cytosilic esterases and trapped as the active chelator.
    Fura-5F AM
  • HY-118847

    Fungal Infection
    Antifungal agent 86 (Compound 41F5) is an antifungal agent. Antifungal agent 86 is highly active against Histoplasma yeast and Cryptococcus neoformans (MIC50: 0.4-0.8 μM) .
    Antifungal agent 86

Inquiry Online

Your information is safe with us. * Required Fields.

Salutation

 

Country or Region *

Applicant Name *

 

Organization Name *

Department *

     

Email Address *

 

Product Name *

Cat. No.

 

Requested quantity *

Phone Number *

     

Remarks

Inquiry Online

Inquiry Information

Product Name:
Cat. No.:
Quantity:
MCE Japan Authorized Agent: